Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor Status
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens Bazedoxifene and Conjugated Estrogens NCT04821141 University of Kansas Medical Center Recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration NCT03317405 National Cancer Institute (NCI) Active, not recruiting
Piloting Pathways With Lung Cancer Patients Pathways NCT04161157 Laurie McLouth Recruiting
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... Denosumab, Salpingo-Oophorectomy NCT03382574 National Cancer Institute (NCI) Recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 ETOP IBCSG Partners Foundation Active, not recruiting
Prevention of Oral DNA Damage by Black Raspberries BRB Lozenges NCT04372914 Milton S. Hershey Medical Center Recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Active, not recruiting
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection... Best Practice, Entecavir, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate NCT03887702 Southwest Oncology Group Recruiting
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Placebo Administration, Rilimogene Galvacirepvec NCT02326805 National Cancer Institute (NCI) Active, not recruiting
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who... Laboratory Biomarker Analysis, Trastuzumab, Whole Breast Irradiation NCT00769379 National Cancer Institute (NCI) Active, not recruiting

Pages